1. Home
  2. LKFN vs BBNX Comparison

LKFN vs BBNX Comparison

Compare LKFN & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Financial Corporation

LKFN

Lakeland Financial Corporation

HOLD

Current Price

$55.50

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$10.93

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKFN
BBNX
Founded
1872
2015
Country
United States
United States
Employees
N/A
423
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
493.1M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
LKFN
BBNX
Price
$55.50
$10.93
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
$67.00
$26.22
AVG Volume (30 Days)
134.5K
1.1M
Earning Date
04-24-2026
05-05-2026
Dividend Yield
3.78%
N/A
EPS Growth
10.47
N/A
EPS
4.01
N/A
Revenue
$985,000.00
N/A
Revenue This Year
$15.08
$34.99
Revenue Next Year
$5.18
$34.47
P/E Ratio
$13.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$50.00
$8.89
52 Week High
$69.38
$32.71

Technical Indicators

Market Signals
Indicator
LKFN
BBNX
Relative Strength Index (RSI) 37.36 34.22
Support Level N/A $9.91
Resistance Level $60.60 $15.53
Average True Range (ATR) 1.46 0.64
MACD -0.19 0.21
Stochastic Oscillator 26.14 35.51

Price Performance

Historical Comparison
LKFN
BBNX

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: